Open AccessSplit high‐dose oral levothyroxine treatment as a successful therapy option in myxedema coma
Author(s) -
Charoensri Suranut,
Sriphrapradang Chutintorn,
Nimitphong Hataikarn
Publication year - 2017
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.1131
Subject(s) - medicine , levothyroxine , myxedema , coma (optics) , radioiodine therapy , thyroid , physics , thyroid cancer , optics
Key Clinical Message High‐dose intravenous thyroxine (T4) is the preferable treatment for myxedema coma. We describe the clinical course of a 69‐year‐old man who presented with myxedema coma and received oral levothyroxine ( LT 4) therapy (1 mg) in a split dose. This suggests split high‐dose oral LT 4 as a therapeutic option in myxedema coma.